Liver Transplants Reach Record Highs in the U.S. What’s Driving Growth?
The number of liver transplants performed in the United States is higher than it’s ever been. For patients in need, including those with end-stage liver disease, acute liver failure or liver cancer, it’s life-saving news.
Clinical Scorecard: Liver Transplants Reach Record Highs in the U.S. What’s Driving Growth?
At a Glance
Category Detail
Condition End-stage liver disease, acute liver failure, liver cancer
Key Mechanisms Increased organ supply via machine perfusion technology, improved recipient screening, efficient patient transfer, emerging xenotransplantation
Target Population Patients requiring liver transplantation including adults and pediatrics
Care Setting Advanced, high-volume transplant centers such as the USC Transplant Institute
Key Highlights
Record-breaking liver transplant numbers in the U.S., reaching 12,344 in 2025. Machine perfusion devices significantly improve donor organ viability and preservation time. Enhanced screening protocols for alcohol-related liver disease improve transplant success rates.
Guideline-Based Recommendations
Diagnosis
Screen patients thoroughly for transplant candidacy, especially in alcohol-associated liver disease. Use multidisciplinary team evaluations including transplant surgeons, hepatologists, and ICU providers.
Management
Utilize machine perfusion technology to preserve donor organs and extend viability. Implement standardized protocols to assess risk of alcohol relapse post-transplant. Facilitate rapid patient transfer to transplant centers with dedicated transfer teams.
Monitoring & Follow-up
Continuously monitor donor organ viability in real-time during machine perfusion. Maintain ongoing multidisciplinary communication to optimize patient outcomes.
Risks
Potential for alcohol relapse post-transplant necessitates careful patient selection. Ischemic damage risk reduced by machine perfusion compared to static cold storage.
Patient & Prescribing Data
Patients with end-stage liver disease, acute liver failure, liver cancer, and alcohol-related liver disease
Advances in organ preservation and patient screening have expanded transplant eligibility and improved outcomes.
Clinical Best Practices
Early referral to transplant centers even before patients reach transplant criteria. Use of normothermic regional perfusion (NRP) as a cost-effective method to improve graft survival. Collaboration with organ procurement organizations to increase access to machine-perfused organs. Continuous multidisciplinary team meetings to review patient cases and optimize care.
References